AIM ImmunoTech Inc.AIMEarnings & Financial Report
NYSE · Health Care · Biological Products, (No Diagnostic Substances)
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Armistice Capital, LLC | 6.84% | 4.3M | — | 2024-11-14 |
| Todd Deutsch | 2.70% | 1.7M | ▼ -0.30pp | 2024-12-17 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-12 | CHEMEROW DAVID I. | Director | Conversion | 25.0K | $0.00 | $0 |
| 2026-03-12 | Equels Thomas K | CEO & President | Conversion | 25.0K | $0.00 | $0 |
| 2026-02-05 | CHEMEROW DAVID I. | Director | Grant | 2.8K | $1.23 | $3.4K |
1–3 of 3